Randy C. Bowen, MD

Randy C. Bowen, MD

5.0 
1181 ratings  Read Reviews
Northwestern Medicine logoNorthwestern Medical Group

Primary Specialty

Ocular Oncology

Secondary Specialty

Is your insurance accepted? Select plan

CALL

HealthBeat

Sunandana Chandra, MD and Bozena Wojtach in a hospital corridor.

Targeted Therapy Opens Up Options for Patients With Rare Eye Cancer That Spreads to Liver

An innovative approach.

Chris Bowen, MD, director of Ocular Oncology at Northwestern Medicine, stands with his patient Debbie Hensley.

Can You Get Eye Cancer?

Treating ocular melanoma with proton therapy.

More HealthBeat Articles

Practice Focus Areas

This medical professional has a particular interest or expertise in:

Reasons to Schedule a Visit

This medical professional may be a good choice for you if you are looking for care for any of the following:

  • Cancer, tumor or mass
  • Choroidal mass
  • Choroidal nevus
  • Iris cyst

Education

Medical Education:
MD, University of Utah School of Medicine - 2015
Internship:
University of Utah Health - 2016
Residency:
University of Wisconsin Hospitals and Clinics - 2019
Fellowships:
Cleveland Clinic Foundation - 2020
University of Iowa Hospitals and Clinics - 2022

Languages Spoken

  • Spanish

Board Certifications

  • American Board of Ophthalmology - Ophthalmology (Certified)

Faculty Profile

Assistant Professor, Feinberg School of Medicine

View Faculty Profile

Practice Groups and Affiliations

Medical Group:
Northwestern Medical Group
On Medical Staff At:
Northwestern Memorial Hospital

Ratings and Reviews

At Northwestern Medicine, our patient’s feedback is important to us. While different care providers have their own unique strengths, we strive to be as transparent as possible with our quality of care.

Read Ratings FAQs

Overall Rating

5.0
5.0 

1181 Ratings

Sort By Newest

Reviews from Patients

100 Most Recent Reviews

Reviews from Patients

Sort By Newest
100 Most Recent Reviews

Disclosures

Industry Relationships

Ownership or Investment Interest

Faculty member and/or their immediate family have an ownership or investment interest in the following companies

  • Stream Dx, Inc.

Royalties

Faculty member and/or their immediate family have the right to receive payments or may receive future financial benefits for inventions or discoveries related to the following companies or other entities

  • Stream Dx, Inc.

External Professional Relationships

Pharmaceutical, device, and biotechnology companies frequently collaborate with basic scientists and physicians within an academic medical center to help advance science and improve patient care. These relationships are important in achieving scientific breakthroughs and in establishing the effectiveness and safety of promising new therapies. In order to assure objectivity in clinical research and patient care, the Northwestern University Feinberg School of Medicine (Feinberg), Northwestern Memorial HealthCare, Children's Hospital of Chicago Medical Center, and the Shirley Ryan AbilityLab have adopted integrity policies that require research and clinical faculty (in full-time, part-time, and unpaid/voluntary categories) to report compensated and uncompensated external industry relationships. Patients are encouraged to discuss these disclosures with their physician as well as to inquire as to how these relationships are overseen by Feinberg. To learn more about our Disclosure and Professional Integrity Policy, and the conflict of interest policies of our joint affiliate survey partners, please go to our Office for Regulatory Affairs Policies page.

View More Disclosures

HealthBeat

Sunandana Chandra, MD and Bozena Wojtach in a hospital corridor.

Targeted Therapy Opens Up Options for Patients With Rare Eye Cancer That Spreads to Liver

An innovative approach.

Chris Bowen, MD, director of Ocular Oncology at Northwestern Medicine, stands with his patient Debbie Hensley.

Can You Get Eye Cancer?

Treating ocular melanoma with proton therapy.

More HealthBeat Articles